UnitedHealth Group Inc (UNH) : Callahan Advisors reduced its stake in UnitedHealth Group Inc by 1.44% during the most recent quarter end. The investment management company now holds a total of 60,792 shares of UnitedHealth Group Inc which is valued at $8,141,265 after selling 886 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on Oct 14, 2016.UnitedHealth Group Inc makes up approximately 2.07% of Callahan Advisors’s portfolio.
Other Hedge Funds, Including , Smithbridge Asset Management Incde boosted its stake in UNH in the latest quarter, The investment management firm added 25 additional shares and now holds a total of 16,425 shares of UnitedHealth Group Inc which is valued at $2,199,636. UnitedHealth Group Inc makes up approx 2.00% of Smithbridge Asset Management Incde’s portfolio.Highland Capital Management reduced its stake in UNH by selling 110 shares or 0.62% in the most recent quarter. The Hedge Fund company now holds 17,607 shares of UNH which is valued at $2,362,683. UnitedHealth Group Inc makes up approx 0.20% of Highland Capital Management’s portfolio.Atria Investments boosted its stake in UNH in the latest quarter, The investment management firm added 1,503 additional shares and now holds a total of 11,450 shares of UnitedHealth Group Inc which is valued at $1,542,888. UnitedHealth Group Inc makes up approx 0.14% of Atria Investments’s portfolio.Community Trust Investment Co reduced its stake in UNH by selling 1,717 shares or 1.27% in the most recent quarter. The Hedge Fund company now holds 133,025 shares of UNH which is valued at $18,368,092. UnitedHealth Group Inc makes up approx 2.34% of Community Trust Investment Co’s portfolio.North Star Asset Management Inc reduced its stake in UNH by selling 27 shares or 0.24% in the most recent quarter. The Hedge Fund company now holds 11,206 shares of UNH which is valued at $1,541,946. UnitedHealth Group Inc makes up approx 0.17% of North Star Asset Management Inc’s portfolio.
UnitedHealth Group Inc closed down -0.27 points or -0.20% at $133.92 with 34,52,918 shares getting traded on Friday. Post opening the session at $134.78, the shares hit an intraday low of $133.89 and an intraday high of $135.51 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, UnitedHealth Group Inc reported $1.96 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.89. The company had revenue of $46485.00 million for the quarter, compared to analysts expectations of $45039.08 million. The company’s revenue was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS.
Many Wall Street Analysts have commented on UnitedHealth Group Inc. UnitedHealth Group Inc was Upgraded by Argus to ” Buy” on Jul 22, 2016. Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 165 from a previous price target of $157 .Company shares were Reiterated by Mizuho on Jul 19, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $156 .
UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.